Haloperidol and Psychomotor hyperactivity - a phase IV clinical study of FDA data

Summary:

We study 14,895 people who have side effects when taking Haloperidol. Psychomotor hyperactivity is found, especially among people who are male, 60+ old, have been taking the drug for < 1 month, also take Olanzapine and have Psychotic disorder.

The phase IV clinical study analyzes which people take Haloperidol and have Psychomotor hyperactivity. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 29, 2023

14,895 people reported to have side effects when taking Haloperidol.
Among them, 111 people (0.75%) have Psychomotor hyperactivity.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is used in schizophrenia. Currently, eHealthMe is studying from 15,095 Haloperidol users.

What is Psychomotor hyperactivity?

Psychomotor hyperactivity (feelings of extreme restlessness) is found to be associated with 1,700 drugs and 1,064 conditions by eHealthMe. Currently, we are studying 19,721 people who have Psychomotor hyperactivity.

Number of Haloperidol and Psychomotor hyperactivity reports submitted per year:

Could Haloperidol cause Psychomotor hyperactivity?

* Approximation only. Some reports may have incomplete information.

Do you take Haloperidol and have Psychomotor hyperactivity?

Check whether Psychomotor hyperactivity is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Obayi, O., & Tagbo, N. , "Bilateral Pedal Oedema Associated with Intramuscular Haloperidol–A Rare Observation", International Neuropsychiatric Disease Journal, 2018 Jan .

Related studies

Haloperidol side effects by duration, gender and age:

Haloperidol side effects (15,095 reports)

Psychomotor hyperactivity treatments and more:

Psychomotor hyperactivity (19,721 reports)

Common drugs associated with Psychomotor hyperactivity:

All the drugs that are associated with Psychomotor hyperactivity:

Psychomotor hyperactivity (1,700 drugs)

Common conditions associated with Psychomotor hyperactivity:

Attention deficit hyperactivity disorder: 1,634 reports
Depression: 1,250 reports
Stress and anxiety: 564 reports
Pain: 550 reports
Asthma: 537 reports
Parkinson's disease: 497 reports

All the conditions that are associated with Psychomotor hyperactivity:

Psychomotor hyperactivity (1,064 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on haloperidol (the active ingredients of Haloperidol) and Haloperidol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.